This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
antibody
product name :
Anti-ANPEP monoclonal antibody, clone XN26 [PerCP/Cy5.5®]
catalog :
DCABH-4880
quantity :
50 Tests
clonality :
monoclonal
host :
mouse
conjugate :
PerCP/Cy5.5
clone name :
XN26
reactivity :
human
application :
flow cytometry
product information
Cat :
DCABH-4880
Product Name :
Anti-ANPEP monoclonal antibody, clone XN26 [PerCP/Cy5.5®]
Brand :
Creative Diagnostics
Abbr :
Anti-ANPEP MAb, PerCP/Cy5.5®-Conjugated
Host animal :
Mouse
Clone :
XN26
Official Symbol :
ANPEP
Clonality :
Monoclonal
Application :
FC
Target :
ANPEP
Species Reactivity :
Human
Conjugate :
PerCP/Cy5.5®
Antibody Type :
Primary Antibodies
Immunogen :
Human AML cells.
Alternative Names :
ANPEP; alanyl (membrane) aminopeptidase; CD13, PEPN; aminopeptidase N; aminopeptidase M; gp150; LAP1; microsomal aminopeptidase; p150; AP-M; AP-N; hAPN; alanyl aminopeptidase; myeloid plasma membrane glycoprotein CD13; APN; CD13; P150; PEPN; GP150;
UniProt ID :
A0A024RC61
Antibody Isotype :
IgG1
Size :
50 Tests
Storage :
Store at +4°C.
company information

Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments